Europe
24 April 2025 As the US legal sector comes under political pressure for its inclusion efforts, LSIPR's sister magazine reveals its Top 100 for 2025, highlighting the individuals fighting to keep progress at the heart of IP.
1 April 2025
Latest Features
Europe
In its first year, uptake of cases at the Unified Patent Court has surpassed most expectations. Darren Smyth of EIP delves into the facts and figures behind the headlines, with some surprising results.
Europe
It remains to be seen whether AI developers in the medical sector will benefit from the UK’s ‘flexible’ regulatory environment or find the lack of cohesion detrimental, say Jackie Mulryne and Beatriz San Martin of Arnold & Porter.
Europe
Is the court’s public access rule unfit for purpose? Lawyers at Mathys & Squire are arguing for pleadings and evidence to be automatically made available on request, finds Muireann Bolger.
Biotechnology
Recent clashes over patents covering modified guide RNAs have exposed different approaches from the US and Europe—and new complications for the field, says Claire Irvine of HGF.
Big Pharma
Despite a rocky start, with case-management issues and plenty of scepticism from stakeholders, there is much to applaud in the UPC’s first four months, write Sebastian Moore and John Lao of Herbert Smith Freehills.
Biotechnology
Although UK research universities were going strong after Horizon funding was pulled, it could have been a different story had the scheme not been reinstated, finds Sarah Speight.
Big Pharma
Revocation and infringement actions involving a cholesterol treatment, prosthetic valves, and methods for analyte detection are among the first to land at the court within its first month, explain Joanne Welch and Darren Smyth of EIP.
Big Pharma
Big pharma company picks pan-European venue for next leg of global dispute | IT issues potentially behind new court's low revocation count | Nearly half a million opt-outs registered.
More News
4 March 2025 UK biotech firm accuses luxury skincare brand La Prairie of misappropriating proprietary research on caviar-derived ingredients | Lawsuit claims La Prairie lacked expertise to develop the tech before accessing confidential trade secrets.
16 January 2025 New analysis examines funding gap for European startups and where to find investment | UK’s active VC market bucks trend in Europe where tech funding largely driven by public programmes.
14 January 2025 IP specialist joins firm’s Bristol office | Transaction expert has advised AstraZeneca, Cancer Research Horizons, and other high-profile clients.
7 January 2025 New partner brings technical background in computer science and more than a decade experience in patent litigation | Expertise in tech, engineering, chemical, and life sciences sectors.
3 December 2024 One-day event in London brings in-house counsel and private practitioners together | First sessions to kick off the day covered European Patent Office procedures, and in-house views on how the UPC is faring.
3 December 2024 Former EIP partner joins IP and technology practice | New London hire is known for high-stakes, cross-border patent litigation.
14 November 2024 Transatlantic deal would make ‘HSF Kramer’ a top 20 global firm by revenue | ‘Transformational’ combination a ‘one-of-a-kind’ opportunity, say firms’ leaders | HSF Kramer would have 2,700 lawyers, including 640 partners across 25 offices | IP practice would have approximately 32 partners.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox